Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 881 All time
- Disclosed funding
- $34.2B 795 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| BT Beyang TherapeuticsCompany profile AI-driven drug discovery company using its ExCEED molecular design platform AI-driven drug discovery company using its ExCEED molecular design platform | $30M | Series A | Biotech | China | Investors | |
| R RemepyCompany profile Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps | $36M | Series A | Biotech | Israel | Investors | |
| C Cytix provides software change risk management for enterprises. | $7M | Series A | Cybersecurity | United Kingdom | Investors | |
| M MindgardCompany profile Mindgard helps enterprise security teams find and address vulnerabilities in AI models, applications and agents. Mindgard helps enterprise security teams find and address vulnerabilities in AI models, applications and agents. | $30M | Series A | Cybersecurity | United Kingdom | Investors | |
| OO Omega OphthalmicsCompany profile Develops an implantable capsule platform to improve outcomes in cataract surgery Develops an implantable capsule platform to improve outcomes in cataract surgery | $7M | Series A | Healthtech | United States | Investors Undisclosed | |
| A AI-native clearinghouse automating insurance verification and policy workflows | $17.5M | Series A | Fintech | United States | Investors | |
| SD Silicon DataCompany profile Provides independent GPU pricing benchmarks and market data for the AI compute economy Provides independent GPU pricing benchmarks and market data for the AI compute economy | $30.5M | Series A | Fintech | United States | Investors | |
| I InfinimmuneCompany profile Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease Develops human-derived antibody therapeutics for atopic dermatitis and inflammatory disease | $75M | Series A | Biotech | United States | Investors | |
| N NaturalCompany profile Natural provides payment infrastructure that lets developers build AI agents capable of making transactions. Natural provides payment infrastructure that lets developers build AI agents capable of making transactions. | $30M | Series A | Fintech | United States | Investors | |
| E EdgifyCompany profile Edgify runs AI on retail devices to recognise products, detect checkout errors and coordinate learning across a store’s equipment. Edgify runs AI on retail devices to recognise products, detect checkout errors and coordinate learning across a store’s equipment. | $9M | Series A+Series A | AI | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.